{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:19:38Z","timestamp":1783700378616,"version":"3.55.0"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYS2019027"],"award-info":[{"award-number":["SYS2019027"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471418, 82001382"],"award-info":[{"award-number":["82471418, 82001382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Natural Science Foundation of China","award":["SBK2020040785"],"award-info":[{"award-number":["SBK2020040785"]}]},{"name":"a project of invigorating healthcare through science, technology, and education","award":["KJXW2019018"],"award-info":[{"award-number":["KJXW2019018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-026-10302-0","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:33:29Z","timestamp":1783654409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting IL-33 in Precision Neuroimmunology: Cellular Mechanisms and Therapeutic Strategies for CNS Disorders"],"prefix":"10.1007","volume":"21","author":[{"given":"Lili","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"10302_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5346413","volume":"2018","author":"MF Abd Rachman Isnadi","year":"2018","unstructured":"Abd Rachman Isnadi MF, Chin VK, Abd Majid R, Lee TY, Atmadini Abdullah M, Bello Omenesa R, Osamah Ibraheem Z, Basir R (2018) Critical roles of IL-33\/ST2 pathway in neurological disorders. Mediators Inflamm 2018:5346413","journal-title":"Mediators Inflamm"},{"key":"10302_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02601","volume":"9","author":"C Afferni","year":"2018","unstructured":"Afferni C, Buccione C, Andreone S, Galdiero MR, Varricchi G, Marone G, Mattei F, Schiavoni G (2018) The pleiotropic immunomodulatory functions of IL-33 and its implications in tumor immunity. Front Immunol 9:2601","journal-title":"Front Immunol"},{"key":"10302_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12931-018-0752-9","volume":"19","author":"H Aizawa","year":"2018","unstructured":"Aizawa H, Koarai A, Shishikura Y, Yanagisawa S, Yamaya M, Sugiura H, Numakura T, Yamada M, Ichikawa T, Fujino N, Noda M, Okada Y, Ichinose M (2018) Oxidative stress enhances the expression of IL-33 in human airway epithelial cells. Respir Res 19:52","journal-title":"Respir Res"},{"key":"10302_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12032-021-01590-y","volume":"39","author":"D Akcora-Yildiz","year":"2022","unstructured":"Akcora-Yildiz D, Yukselten Y, Sunguroglu M, Ugur HC, Sunguroglu A (2022) IL-33 induces ADAMTS5 expression and cell migration in glioblastoma multiforme. Med Oncol 39:22","journal-title":"Med Oncol"},{"key":"10302_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.bbrc.2009.12.107","volume":"391","author":"S Ali","year":"2010","unstructured":"Ali S, Nguyen DQ, Falk W, Martin MU (2010) Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. Biochem Biophys Res Commun 391:1512\u20131516","journal-title":"Biochem Biophys Res Commun"},{"key":"10302_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-016-0344-1","volume":"4","author":"D Allan","year":"2016","unstructured":"Allan D, Fairlie-Clarke KJ, Elliott C, Schuh C, Barnett SC, Lassmann H, Linnington C, Jiang HR (2016) Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system. Acta Neuropathol Commun 4:75","journal-title":"Acta Neuropathol Commun"},{"key":"10302_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/bmc-2016-0026","volume":"8","author":"F Alsahebfosoul","year":"2017","unstructured":"Alsahebfosoul F, Rahimmanesh I, Shajarian M, Etemadifar M, Sedaghat N, Hejazi Z, Naderi S (2017) Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis. Biomol Concepts 8:55\u201360","journal-title":"Biomol Concepts"},{"key":"10302_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11910-023-01282-2","volume":"23","author":"DL Alsbrook","year":"2023","unstructured":"Alsbrook DL, Di Napoli M, Bhatia K, Biller J, Andalib S, Hinduja A, Rodrigues R, Rodriguez M, Sabbagh SY, Selim M, Farahabadi MH, Jafarli A, Divani AA (2023) Neuroinflammation in acute ischemic and hemorrhagic stroke. Curr Neurol Neurosci Rep 23:407\u2013431","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10302_CR9","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1038\/s41467-021-26347-z","volume":"12","author":"I Aneas","year":"2021","unstructured":"Aneas I et al (2021) Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region. Nat Commun 12:6115","journal-title":"Nat Commun"},{"key":"10302_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG (2022) Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities. Cells 11:2908","journal-title":"Cells"},{"key":"10302_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-019-1625-y","volume":"16","author":"J Augustine","year":"2019","unstructured":"Augustine J, Pavlou S, Ali I, Harkin K, Ozaki E, Campbell M, Stitt AW, Xu H, Chen M (2019) IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment. J Neuroinflammation 16:251","journal-title":"J Neuroinflammation"},{"key":"10302_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126766","volume":"6","author":"B Baban","year":"2021","unstructured":"Baban B, Braun M, Khodadadi H, Ward A, Alverson K, Malik A, Nguyen K, Nazarian S, Hess DC, Forseen S, Post AF, Vale FL, Vender JR, Hoda MN, Akbari O, Vaibhav K, Dhandapani KM (2021) AMPK induces regulatory innate lymphoid cells after traumatic brain injury. JCI Insight 6:e126766","journal-title":"JCI Insight"},{"key":"10302_CR13","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.1074\/jbc.M111.295055","volume":"287","author":"S Bae","year":"2012","unstructured":"Bae S, Kang T, Hong J, Lee S, Choi J, Jhun H, Kwak A, Hong K, Kim E, Jo S, Kim S (2012) Contradictory functions (activation\/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity. J Biol Chem 287:8205\u20138213","journal-title":"J Biol Chem"},{"key":"10302_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","volume":"163","author":"ES Baekkevold","year":"2003","unstructured":"Baekkevold ES, Roussign\u00e9 M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard JP (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163:69\u201379","journal-title":"Am J Pathol"},{"key":"10302_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2018.02.012","volume":"318","author":"M Barbour","year":"2018","unstructured":"Barbour M, Wood R, Hridi SU, Wilson C, McKay G, Bushell TJ, Jiang HR (2018) The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels. J Neuroimmunol 318:87\u201396","journal-title":"J Neuroimmunol"},{"key":"10302_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","volume":"188","author":"KR Bartemes","year":"2012","unstructured":"Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H (2012) IL-33-responsive lineage- CD25\u2009+\u2009CD44 (hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188:1503\u20131513","journal-title":"J Immunol"},{"key":"10302_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/S415","volume":"6","author":"JM Beitz","year":"2014","unstructured":"Beitz JM (2014) Parkinson\u2019s disease: a review. Front Biosci (Schol Ed) 6:65\u201374","journal-title":"Front Biosci (Schol Ed)"},{"key":"10302_CR18","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/j.1460-2075.1994.tb06367.x","volume":"13","author":"G Bergers","year":"1994","unstructured":"Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M (1994) Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 13:1176\u20131188","journal-title":"EMBO J"},{"key":"10302_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004607","volume":"11","author":"AG Besnard","year":"2015","unstructured":"Besnard AG, Guabiraba R, Niedbala W, Palomo J, Reverchon F, Shaw TN, Couper KN, Ryffel B, Liew FY (2015) IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells. PLoS Pathog 11:e1004607","journal-title":"PLoS Pathog"},{"key":"10302_CR20","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1038\/ncomms6488","volume":"5","author":"AH Buck","year":"2014","unstructured":"Buck AH, Coakley G, Simbari F, McSorley HJ, Quintana JF, Le Bihan T, Kumar S, Abreu-Goodger C, Lear M, Harcus Y, Ceroni A, Babayan SA, Blaxter M, Ivens A, Maizels RM (2014) Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun 5:5488","journal-title":"Nat Commun"},{"key":"10302_CR21","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.4049\/jimmunol.0802729","volume":"182","author":"K Bulek","year":"2009","unstructured":"Bulek K, Swaidani S, Qin J, Lu Y, Gulen MF, Herjan T, Min B, Kastelein RA, Aronica M, Kosz-Vnenchak M, Li X (2009) The essential role of single Ig IL-1 receptor-related molecule\/Toll IL-1R8 in regulation of Th2 immune response. J Immunol 182:2601\u20132609","journal-title":"J Immunol"},{"key":"10302_CR22","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0144-2022","volume":"32","author":"AA Calderon","year":"2023","unstructured":"Calderon AA, Dimond C, Choy DF, Pappu R, Grimbaldeston MA, Mohan D, Chung KF (2023) Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. Eur Respir Rev 32:225144","journal-title":"Eur Respir Rev"},{"key":"10302_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions. Alzheimers Dement 12:719\u2013732","journal-title":"Alzheimers Dement"},{"key":"10302_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T (2022) Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities. Stroke 53:1473\u20131486","journal-title":"Stroke"},{"key":"10302_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.31083\/j.jin2205132","volume":"22","author":"C Cattaneo","year":"2023","unstructured":"Cattaneo C, Jost WH (2023) Pain in Parkinson\u2019s Disease: Pathophysiology, Classification and Treatment. J Integr Neurosci 22:132","journal-title":"J Integr Neurosci"},{"key":"10302_CR26","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106:9021\u20139026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10302_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP (2018) Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. Immunol Rev 281:154\u2013168","journal-title":"Immunol Rev"},{"key":"10302_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","volume":"15","author":"\u00c1 Chamorro","year":"2016","unstructured":"Chamorro \u00c1, Dirnagl U, Urra X, Planas AM (2016) Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15:869\u2013881","journal-title":"Lancet Neurol"},{"key":"10302_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fimmu.2019.00364","volume":"10","author":"BCL Chan","year":"2019","unstructured":"Chan BCL, Lam CWK, Tam LS, Wong CK (2019) IL33: Roles in Allergic Inflammation and Therapeutic Perspectives. Front Immunol 10:364","journal-title":"Front Immunol"},{"key":"10302_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semcdb.2020.08.001","volume":"112","author":"B Chausse","year":"2021","unstructured":"Chausse B, Kakimoto PA, Kann O (2021) Microglia and lipids: how metabolism controls brain innate immunity. Semin Cell Dev Biol 112:137\u2013144","journal-title":"Semin Cell Dev Biol"},{"key":"10302_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.actatropica.2017.05.023","volume":"173","author":"AC Chen","year":"2017","unstructured":"Chen AC, Shyu LY, Hsin YL, Chen KM, Lai SC (2017) Resveratrol relieves Angiostrongylus cantonensis - Induced meningoencephalitis by activating sirtuin-1. Acta Trop 173:76\u201384","journal-title":"Acta Trop"},{"key":"10302_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2015.09.019","volume":"308","author":"H Chen","year":"2015","unstructured":"Chen H, Sun Y, Lai L, Wu H, Xiao Y, Ming B, Gao M, Zou H, Xiong P, Xu Y, Tan Z, Gong F, Zheng F (2015) Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice. Neuroscience 308:157\u2013168","journal-title":"Neuroscience"},{"key":"10302_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen Z, Bozec A, Ramming A, Schett G (2019a) Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 15:9\u201317","journal-title":"Nat Rev Rheumatol"},{"key":"10302_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainresbull.2019.05.016","volume":"150","author":"Z Chen","year":"2019","unstructured":"Chen Z, Xu N, Dai X, Zhao C, Wu X, Shankar S, Huang H, Wang Z (2019b) Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats. Brain Res Bull 150:127\u2013135","journal-title":"Brain Res Bull"},{"key":"10302_CR35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clim.2011.11.007","volume":"142","author":"GP Christophi","year":"2012","unstructured":"Christophi GP, Gruber RC, Panos M, Christophi RL, Jubelt B, Massa PT (2012) Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol 142:308\u2013319","journal-title":"Clin Immunol"},{"key":"10302_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.713336","volume":"15","author":"YH Chung","year":"2021","unstructured":"Chung YH, Qian Q, Huang HY, Chiu WT, Yang CS, Tzeng SF (2021) The nuclear function of IL-33 in desensitization to DNA damaging agent and change of glioma nuclear structure. Front Cell Neurosci 15:713336","journal-title":"Front Cell Neurosci"},{"key":"10302_CR37","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP (2017) Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140:527\u2013546","journal-title":"Brain"},{"key":"10302_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-019-1571-8","volume":"16","author":"S Dabrowska","year":"2019","unstructured":"Dabrowska S, Andrzejewska A, Lukomska B, Janowski M (2019) Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation 16:178","journal-title":"J Neuroinflammation"},{"key":"10302_CR39","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1038\/s41467-020-18466-w","volume":"11","author":"R Dagher","year":"2020","unstructured":"Dagher R, Copenhaver AM, Besnard V, Berlin A, Hamidi F, Maret M, Wang J, Qu X, Shrestha Y, Wu J, Gautier G, Raja R, Aubier M, Kolbeck R, Humbles AA, Pretolani M (2020) IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration. Nat Commun 11:4786","journal-title":"Nat Commun"},{"key":"10302_CR40","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1038\/s41467-020-18569-4","volume":"11","author":"A De Boeck","year":"2020","unstructured":"De Boeck A et al (2020) Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. Nat Commun 11:4997","journal-title":"Nat Commun"},{"key":"10302_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","volume":"26","author":"M De la Fuente","year":"2015","unstructured":"De la Fuente M, MacDonald TT, Hermoso MA (2015) The IL-33\/ST2 axis: Role in health and disease. Cytokine Growth Factor Rev 26:615\u2013623","journal-title":"Cytokine Growth Factor Rev"},{"key":"10302_CR42","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acschemneuro.2c00196","volume":"13","author":"Z Do\u011fanyi\u011fit","year":"2022","unstructured":"Do\u011fanyi\u011fit Z, Erbakan K, Akyuz E, Polat AK, Arulsamy A, Shaikh MF (2022) The Role of Neuroinflammatory Mediators in the Pathogenesis of Traumatic Brain Injury: A Narrative Review. ACS Chem Neurosci 13:1835\u20131848","journal-title":"ACS Chem Neurosci"},{"key":"10302_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/imr.12552","volume":"278","author":"LY Drake","year":"2017","unstructured":"Drake LY, Kita H (2017) IL-33: biological properties, functions, and roles in airway disease. Immunol Rev 278:173\u2013184","journal-title":"Immunol Rev"},{"key":"10302_CR44","doi-asserted-by":"publisher","first-page":"110578","DOI":"10.1016\/j.intimp.2023.110578","volume":"122","author":"S Duan","year":"2023","unstructured":"Duan S, Wang J, Lou X, Chen D, Shi P, Jiang H, Wang Z, Li W, Qian F (2023) A novel anti-IL-33 antibody recognizes an epitope FVLHN of IL-33 and has a therapeutic effect on inflammatory diseases. Int Immunopharmacol 122:110578","journal-title":"Int Immunopharmacol"},{"key":"10302_CR45","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/ATVBAHA.120.314832","volume":"40","author":"C Duez","year":"2020","unstructured":"Duez C, Gross B, Marquillies P, Ledroit V, Ryffel B, Glineur C (2020) Regulation of IL (Interleukin)-33 Production in Endothelial Cells via Kinase Activation and Fas\/CD95 Upregulation. Arterioscler Thromb Vasc Biol 40:2619\u20132631","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10302_CR46","doi-asserted-by":"publisher","first-page":"106738","DOI":"10.1016\/j.eplepsyres.2021.106738","volume":"176","author":"O Ethemoglu","year":"2021","unstructured":"Ethemoglu O, Cal\u0131k M, Koyuncu I, Ethemoglu KB, G\u00f6cmen A, G\u00fczelcicek A, Cad\u0131rc\u0131 D (2021) Interleukin-33 and oxidative stress in epilepsy patients. Epilepsy Res 176:106738","journal-title":"Epilepsy Res"},{"key":"10302_CR47","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/neuonc\/not234","volume":"16","author":"KM Fang","year":"2014","unstructured":"Fang KM, Yang CS, Lin TC, Chan TC, Tzeng SF (2014) Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells. Neuro Oncol 16:552\u2013566","journal-title":"Neuro Oncol"},{"key":"10302_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.20411\/pai.v7i1.499","volume":"7","author":"EM Fernander","year":"2022","unstructured":"Fernander EM, Adogamhe P, Datta D, Bond C, Zhao Y, Bangirana P, Conroy AL, Opoka RO, John CC (2022) Elevated Plasma Soluble ST2 Levels are Associated With Neuronal Injury and Neurocognitive Impairment in Children With Cerebral Malaria. Pathog Immun 7:60\u201380","journal-title":"Pathog Immun"},{"key":"10302_CR49","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.4049\/jimmunol.1901321","volume":"205","author":"CM Finlay","year":"2020","unstructured":"Finlay CM, Cunningham KT, Doyle B, Mills KHG (2020) IL-33-Stimulated Murine Mast Cells Polarize Alternatively Activated Macrophages, Which Suppress T Cells That Mediate Experimental Autoimmune Encephalomyelitis. J Immunol 205:1909\u20131919","journal-title":"J Immunol"},{"key":"10302_CR50","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.122.063014","volume":"147","author":"N Florens","year":"2023","unstructured":"Florens N, Kasam RK, Rudman-Melnick V, Lin SC, Prasad V, Molkentin JD (2023) Interleukin-33 Mediates Cardiomyopathy After Acute Kidney Injury by Signaling to Cardiomyocytes. Circulation 147:746\u2013758","journal-title":"Circulation"},{"key":"10302_CR51","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","volume":"113","author":"AK Fu","year":"2016","unstructured":"Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, Cheung TH, Zhang B, Fu WY, Liew FY, Ip NY (2016) IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A 113:E2705\u20132713","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10302_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cellsig.2010.10.006","volume":"23","author":"M Funakoshi-Tago","year":"2011","unstructured":"Funakoshi-Tago M, Tago K, Sato Y, Tominaga S, Kasahara T (2011) JAK2 is an important signal transducer in IL-33-induced NF-\u03baB activation. Cell Signal 23:363\u2013370","journal-title":"Cell Signal"},{"key":"10302_CR53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","volume":"85","author":"SP Gadani","year":"2015","unstructured":"Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J (2015) The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85:703\u2013709","journal-title":"Neuron"},{"key":"10302_CR54","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/aps.2013.34","volume":"34","author":"B Gao","year":"2013","unstructured":"Gao B, Zhang XY, Han R, Zhang TT, Chen C, Qin ZH, Sheng R (2013) The endoplasmic reticulum stress inhibitor salubrinal inhibits the activation of autophagy and neuroprotection induced by brain ischemic preconditioning. Acta Pharmacol Sin 34:657\u2013666","journal-title":"Acta Pharmacol Sin"},{"key":"10302_CR55","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fnins.2020.00898","volume":"14","author":"Y Gao","year":"2020","unstructured":"Gao Y, Luo C, Yao Y, Huang J, Fu H, Xia C, Ye G, Yu L, Han J, Fan Y, Tao L (2020) IL-33 Alleviated Brain Damage via Anti-apoptosis, Endoplasmic Reticulum Stress, and Inflammation After Epilepsy. Front Neurosci 14:898","journal-title":"Front Neurosci"},{"key":"10302_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fnmol.2017.00423","volume":"10","author":"Y Gao","year":"2017","unstructured":"Gao Y, Luo CL, Li LL, Ye GH, Gao C, Wang HC, Huang WW, Wang T, Wang ZF, Ni H, Chen XP, Tao LY (2017b) IL-33 Provides Neuroprotection through Suppressing Apoptotic, Autophagic and NF-\u03baB-Mediated Inflammatory Pathways in a Rat Model of Recurrent Neonatal Seizure. Front Mol Neurosci 10:423","journal-title":"Front Mol Neurosci"},{"key":"10302_CR57","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1007\/s12035-016-9947-6","volume":"54","author":"Y Gao","year":"2017","unstructured":"Gao Y, Ma L, Luo CL, Wang T, Zhang MY, Shen X, Meng HH, Ji MM, Wang ZF, Chen XP, Tao LY (2017a) IL-33 Exerts Neuroprotective Effect in Mice Intracerebral Hemorrhage Model Through Suppressing Inflammation\/Apoptotic\/Autophagic Pathway. Mol Neurobiol 54:3879\u20133892","journal-title":"Mol Neurobiol"},{"key":"10302_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.freeradbiomed.2023.02.014","volume":"199","author":"Y Gao","year":"2023","unstructured":"Gao Y, Wang T, Cheng Y, Wu Y, Zhu L, Gu Z, Wu Y, Cai L, Wu Y, Zhang Y, Gao C, Li L, Li J, Li Q, Wang Z, Wang Y, Wang F, Luo C, Tao L (2023) Melatonin ameliorates neurological deficits through MT2\/IL-33\/ferritin H signaling-mediated inhibition of neuroinflammation and ferroptosis after traumatic brain injury. Free Radic Biol Med 199:97\u2013112","journal-title":"Free Radic Biol Med"},{"key":"10302_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fncel.2018.00095","volume":"12","author":"Y Gao","year":"2018","unstructured":"Gao Y, Zhang MY, Wang T, Fan YY, Yu LS, Ye GH, Wang ZF, Gao C, Wang HC, Luo CL, Tao LY (2018) IL-33\/ST2L Signaling Provides Neuroprotection Through Inhibiting Autophagy, Endoplasmic Reticulum Stress, and Apoptosis in a Mouse Model of Traumatic Brain Injury. Front Cell Neurosci 12:95","journal-title":"Front Cell Neurosci"},{"key":"10302_CR60","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg N, Smith TW (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav 5:e00362","journal-title":"Brain Behav"},{"key":"10302_CR61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147671","volume":"6","author":"S Georgakis","year":"2021","unstructured":"Georgakis S, Gkirtzimanaki K, Papadaki G, Gakiopoulou H, Drakos E, Eloranta ML, Makridakis M, Kontostathi G, Zoidakis J, Baira E, R\u00f6nnblom L, Boumpas DT, Sidiropoulos P, Verginis P, Bertsias G (2021) NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-\u03b1 production in patients with SLE. JCI Insight 6:e147671","journal-title":"JCI Insight"},{"key":"10302_CR62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/14737175.2018.1465410","volume":"18","author":"U Geronzi","year":"2018","unstructured":"Geronzi U, Lotti F, Grosso S (2018) Oxidative stress in epilepsy. Expert Rev Neurother 18:427\u2013434","journal-title":"Expert Rev Neurother"},{"key":"10302_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113457","author":"C Glineur","year":"2022","unstructured":"Glineur C, Leleu I, Pied S (2022) The IL-33\/ST2 pathway in cerebral malaria. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113457","journal-title":"Int J Mol Sci"},{"key":"10302_CR64","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/jnc.12784","volume":"130","author":"CD G\u00f3mez","year":"2014","unstructured":"G\u00f3mez CD, Buijs RM, Sitges M (2014) The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1\u03b2 and TNF-\u03b1 expression in rat hippocampus. J Neurochem 130:770\u2013779","journal-title":"J Neurochem"},{"key":"10302_CR65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME (2021) New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol 20:222\u2013234","journal-title":"Lancet Neurol"},{"key":"10302_CR66","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3892\/ol.2016.4626","volume":"12","author":"D Gramatzki","year":"2016","unstructured":"Gramatzki D, Frei K, Cathomas G, Moch H, Weller M, Mertz KD (2016) Interleukin-33 in human gliomas: expression and prognostic significance. Oncol Lett 12:445\u2013452","journal-title":"Oncol Lett"},{"key":"10302_CR67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000533984","volume":"30","author":"S Guo","year":"2023","unstructured":"Guo S, Qian C, Li W, Zeng Z, Cai J, Luo Y (2023) Modulation of Neuroinflammation: Advances in Roles and Mechanisms of the IL-33\/ST2 Axis Involved in Ischemic Stroke. Neuroimmunomodulation 30:226\u2013236","journal-title":"Neuroimmunomodulation"},{"key":"10302_CR68","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.3390\/molecules27207080","volume":"27","author":"Y Guo","year":"2022","unstructured":"Guo Y, Dai W, Zheng Y, Qiao W, Chen W, Peng L, Zhou H, Zhao T, Liu H, Zheng F, Sun P (2022) Mechanism and Regulation of Microglia Polarization in Intracerebral Hemorrhage. Molecules 27:7080","journal-title":"Molecules"},{"key":"10302_CR69","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.immuni.2012.06.012","volume":"37","author":"TY Halim","year":"2012","unstructured":"Halim TY, MacLaren A, Romanish MT, Gold MJ, McNagny KM, Takei F (2012) Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 37:463\u2013474","journal-title":"Immunity"},{"key":"10302_CR70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbrc.2009.07.018","volume":"387","author":"M Hayakawa","year":"2009","unstructured":"Hayakawa M, Hayakawa H, Matsuyama Y, Tamemoto H, Okazaki H, Tominaga S (2009) Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. Biochem Biophys Res Commun 387:218\u2013222","journal-title":"Biochem Biophys Res Commun"},{"key":"10302_CR71","doi-asserted-by":"publisher","first-page":"e1372252025","DOI":"10.1523\/JNEUROSCI.1372-25.2025","volume":"45","author":"YL He","year":"2025","unstructured":"He YL, Niu L, Wang C, Liao ZP, Liu K, Gao S, Du AC, Liu WG, Jia J, Zhang YB, Yin H, Yuan GQ, Pan YW (2025) The Role of Chaf1b in Maintaining Glioma Stem Cell Stemness and Regulating Microglial Polarization. J Neurosci 45:e1372252025","journal-title":"J Neurosci"},{"key":"10302_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ijc.21258","volume":"118","author":"J Held-Feindt","year":"2006","unstructured":"Held-Feindt J, Paredes EB, Bl\u00f6mer U, Seidenbecher C, Stark AM, Mehdorn HM, Mentlein R (2006) Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer 118:55\u201361","journal-title":"Int J Cancer"},{"key":"10302_CR73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201234","volume":"218","author":"S Hemmers","year":"2021","unstructured":"Hemmers S, Schizas M, Rudensky AY (2021) T reg cell-intrinsic requirements for ST2 signaling in health and neuroinflammation. J Exp Med 218:e20201234","journal-title":"J Exp Med"},{"key":"10302_CR74","doi-asserted-by":"publisher","first-page":"20078","DOI":"10.1074\/jbc.M111.219089","volume":"286","author":"J Hong","year":"2011","unstructured":"Hong J, Bae S, Jhun H, Lee S, Choi J, Kang T, Kwak A, Hong K, Kim E, Jo S, Kim S (2011) Identification of constitutively active interleukin 33 (IL-33) splice variant. J Biol Chem 286:20078\u201320086","journal-title":"J Biol Chem"},{"key":"10302_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011944","volume":"5","author":"CL Hsu","year":"2010","unstructured":"Hsu CL, Neilsen CV, Bryce PJ (2010) IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 5:e11944","journal-title":"PLoS One"},{"key":"10302_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12974-017-1021-4","volume":"15","author":"SJ Huang","year":"2018","unstructured":"Huang SJ, Yan JQ, Luo H, Zhou LY, Luo JG (2018) IL-33\/ST2 signaling contributes to radicular pain by modulating MAPK and NF-\u03baB activation and inflammatory mediator expression in the spinal cord in rat models of noncompressive lumber disk herniation. J Neuroinflammation 15:12","journal-title":"J Neuroinflammation"},{"key":"10302_CR77","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1177\/0271678X21996177","volume":"41","author":"K Huo","year":"2021","unstructured":"Huo K, Wei M, Zhang M, Wang Z, Pan P, Shaligram SS, Huang J, Prado LBD, Wong J, Su H (2021) Reduction of neuroinflammation alleviated mouse post bone fracture and stroke memory dysfunction. J Cereb Blood Flow Metab 41:2162\u20132173","journal-title":"J Cereb Blood Flow Metab"},{"key":"10302_CR78","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000321870","volume":"31","author":"BY Hwang","year":"2011","unstructured":"Hwang BY, Appelboom G, Ayer A, Kellner CP, Kotchetkov IS, Gigante PR, Haque R, Kellner M, Connolly ES (2011) Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis 31:211\u2013222","journal-title":"Cerebrovasc Dis"},{"key":"10302_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1515\/revneuro-2023-0128","volume":"35","author":"A Ildarabadi","year":"2024","unstructured":"Ildarabadi A, Mir Mohammad Ali SN, Rahmani F, Mosavari N, Pourbakhtyaran E, Rezaei N (2024) Inflammation and oxidative stress in epileptic children: from molecular mechanisms to clinical application of ketogenic diet. Rev Neurosci 35:473\u2013488","journal-title":"Rev Neurosci"},{"key":"10302_CR80","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/toxsci\/kfz114","volume":"170","author":"Y Ishihara","year":"2019","unstructured":"Ishihara Y, Haarmann-Stemmann T, Kado NY, Vogel CFA (2019) Interleukin 33 expression induced by aryl hydrocarbon receptor in macrophages. Toxicol Sci 170:404\u2013414","journal-title":"Toxicol Sci"},{"key":"10302_CR81","first-page":"69","volume":"23","author":"N Jafariaghdam","year":"2024","unstructured":"Jafariaghdam N, Khoshmirsafa M, Zamani A, Talebi-Ghane E, Moradi S, Shahba F, Mazdeh M, Eftekharian MM (2024) Different gene expression patterns of IL-1 family members in Parkinson\u2019s disease: results from Bayesian regression model. Iran J Allergy Asthma Immunol 23:69\u201381","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10302_CR82","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA (2019) Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation 16:142","journal-title":"J Neuroinflammation"},{"key":"10302_CR83","first-page":"46","volume":"12","author":"ZX Jia","year":"2025","unstructured":"Jia ZX, Guo MT, Li MM, Liao P, Yan B, Zhang W, Cheng FY, Liu YR, Zhang ZH, Wei C, Zhou J, Chen FL, Lei P, Ge XT (2025) Decreased IL-33 in the brain following repetitive mild traumatic brain injury contributes to cognitive impairment by inhibiting microglial phagocytosis. Mil Med Res 12:46","journal-title":"Mil Med Res"},{"key":"10302_CR84","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/eji.201141947","volume":"42","author":"HR Jiang","year":"2012","unstructured":"Jiang HR, Milovanovi\u0107 M, Allan D, Niedbala W, Besnard AG, Fukada SY, Alves-Filho JC, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-\u03b3 production and inducing alternatively activated macrophages. Eur J Immunol 42:1804\u20131814","journal-title":"Eur J Immunol"},{"key":"10302_CR85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-018-1124-6","volume":"15","author":"M Jiang","year":"2018","unstructured":"Jiang M, Liu X, Zhang D, Wang Y, Hu X, Xu F, Jin M, Cao F, Xu L (2018) Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33\/ST2 axis-mediated microglia\/macrophage M2 polarization. J Neuroinflammation 15:78","journal-title":"J Neuroinflammation"},{"key":"10302_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2023.107773","volume":"230","author":"T Jiang","year":"2023","unstructured":"Jiang T, Zheng T, Li W, Liu N, Wang M (2023) IL-33\/ST2 signaling pathway and Alzheimer\u2019s disease: a systematic review and meta-analysis. Clin Neurol Neurosurg 230:107773","journal-title":"Clin Neurol Neurosurg"},{"key":"10302_CR87","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s43587-022-00241-9","volume":"2","author":"Y Jiang","year":"2022","unstructured":"Jiang Y et al (2022) An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-\u03b54 in female patients with Alzheimer\u2019s disease. Nat Aging 2:616\u2013634","journal-title":"Nat Aging"},{"key":"10302_CR88","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-020-01932-z","volume":"17","author":"M Jiao","year":"2020","unstructured":"Jiao M, Li X, Chen L, Wang X, Yuan B, Liu T, Dong Q, Mei H, Yin H (2020) Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury. J Neuroinflammation 17:251","journal-title":"J Neuroinflammation"},{"key":"10302_CR89","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Park J, Hall CK, Lin CJ, Chen M, von Maydell D, Kruskop JM, Kang B, Choi Y, Prokopenko D, Irimia D, Kim DY, Tanzi RE (2023) Infiltrating CD8 (+) T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci 26:1489\u20131504","journal-title":"Nat Neurosci"},{"key":"10302_CR90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/imr.12706","volume":"286","author":"H Kabata","year":"2018","unstructured":"Kabata H, Moro K, Koyasu S (2018) The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev 286:37\u201352","journal-title":"Immunol Rev"},{"key":"10302_CR91","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT (2008) The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7:827\u2013840","journal-title":"Nat Rev Drug Discov"},{"key":"10302_CR92","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"TI Kam","year":"2020","unstructured":"Kam TI, Hinkle JT, Dawson TM, Dawson VL (2020) Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol Dis 144:105028","journal-title":"Neurobiol Dis"},{"key":"10302_CR93","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11481-013-9439-7","volume":"8","author":"D Kempuraj","year":"2013","unstructured":"Kempuraj D, Khan MM, Thangavel R, Xiong Z, Yang E, Zaheer A (2013) Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J Neuroimmune Pharmacol 8:643\u2013650","journal-title":"J Neuroimmune Pharmacol"},{"key":"10302_CR94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11481-017-9766-1","volume":"13","author":"D Kempuraj","year":"2018","unstructured":"Kempuraj D, Selvakumar GP, Zaheer S, Thangavel R, Ahmed ME, Raikwar S, Govindarajan R, Iyer S, Zaheer A (2018) Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson\u2019s Disease. J Neuroimmune Pharmacol 13:100\u2013112","journal-title":"J Neuroimmune Pharmacol"},{"key":"10302_CR95","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s12035-018-1177-7","volume":"56","author":"D Kempuraj","year":"2019","unstructured":"Kempuraj D, Thangavel R, Selvakumar GP, Ahmed ME, Zaheer S, Raikwar SP, Zahoor H, Saeed D, Dubova I, Giler G, Herr S, Iyer SS, Zaheer A (2019) Mast cell proteases activate astrocytes and glia-neurons and release interleukin-33 by activating p38 and ERK1\/2 MAPKs and NF-\u03baB. Mol Neurobiol 56:1681\u20131693","journal-title":"Mol Neurobiol"},{"key":"10302_CR96","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3233\/JAD-210026","volume":"80","author":"H Khodadadi","year":"2021","unstructured":"Khodadadi H, Salles \u00c9L, Jarrahi A, Costigliola V, Khan MB, Yu JC, Morgan JC, Hess DC, Vaibhav K, Dhandapani KM, Baban B (2021) Cannabidiol ameliorates cognitive function via regulation of IL-33 and TREM2 upregulation in a murine model of Alzheimer\u2019s disease. J Alzheimers Dis 80:973\u2013977","journal-title":"J Alzheimers Dis"},{"key":"10302_CR97","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ibror.2019.01.005","volume":"6","author":"P Korhonen","year":"2019","unstructured":"Korhonen P, Pollari E, Kanninen KM, Savchenko E, Lehtonen \u0160, Wojciechowski S, Pomeshchik Y, Van Den Bosch L, Goldsteins G, Koistinaho J, Malm T (2019) Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis. IBRO Rep 6:74\u201386","journal-title":"IBRO Rep"},{"key":"10302_CR98","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/STROKEAHA.111.639989","volume":"43","author":"PR Krafft","year":"2012","unstructured":"Krafft PR, Altay O, Rolland WB, Duris K, Lekic T, Tang J, Zhang JH (2012) \u03b17 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK-3\u03b2 inhibition in a mouse model of intracerebral hemorrhage. Stroke 43:844\u2013850","journal-title":"Stroke"},{"key":"10302_CR99","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.4049\/jimmunol.0901575","volume":"183","author":"M Kurowska-Stolarska","year":"2009","unstructured":"Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, Pitman N, Mirchandani A, Rana B, van Rooijen N, Shepherd M, McSharry C, McInnes IB, Xu D, Liew FY (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183:6469\u20136477","journal-title":"J Immunol"},{"key":"10302_CR100","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.immuni.2009.06.011","volume":"31","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi M, Dixit VM (2009) IL-33 raises alarm. Immunity 31:5\u20137","journal-title":"Immunity"},{"key":"10302_CR101","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/ijms19092676","volume":"19","author":"KM Larsen","year":"2018","unstructured":"Larsen KM, Minaya MK, Vaish V, Pe\u00f1a MMO (2018) The Role of IL-33\/ST2 Pathway in Tumorigenesis. Int J Mol Sci 19:2676","journal-title":"Int J Mol Sci"},{"key":"10302_CR102","doi-asserted-by":"publisher","first-page":"107530","DOI":"10.1016\/j.celrep.2020.107530","volume":"31","author":"SF Lau","year":"2020","unstructured":"Lau SF, Chen C, Fu WY, Qu JY, Cheung TH, Fu AKY, Ip NY (2020) IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer\u2019s Disease. Cell Rep 31:107530","journal-title":"Cell Rep"},{"key":"10302_CR103","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"3","author":"SF Lau","year":"2023","unstructured":"Lau SF, Wu W, Wong HY, Ouyang L, Qiao Y, Xu J, Lau JH, Wong C, Jiang Y, Holtzman DM, Fu AKY, Ip NY (2023) The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat Aging 3:1219\u20131236","journal-title":"Nat Aging"},{"key":"10302_CR104","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.1115884109","volume":"109","author":"E Lefran\u00e7ais","year":"2012","unstructured":"Lefran\u00e7ais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, Cayrol C (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 109:1673\u20131678","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10302_CR105","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1006\/geno.2000.6269","volume":"67","author":"H Li","year":"2000","unstructured":"Li H, Tago K, Io K, Kuroiwa K, Arai T, Iwahana H, Tominaga S, Yanagisawa K (2000) The cloning and nucleotide sequence of human ST2L cDNA. Genomics 67:284\u2013290","journal-title":"Genomics"},{"key":"10302_CR106","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneuroim.2012.03.016","volume":"247","author":"M Li","year":"2012","unstructured":"Li M, Li Y, Liu X, Gao X, Wang Y (2012) IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL\/6 mice. J Neuroimmunol 247:25\u201331","journal-title":"J Neuroimmunol"},{"key":"10302_CR107","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ced.12464","volume":"40","author":"P Li","year":"2015","unstructured":"Li P, Ma H, Han D, Mou K (2015) Interleukin-33 affects cytokine production by keratinocytes in vitiligo. Clin Exp Dermatol 40:163\u2013170","journal-title":"Clin Exp Dermatol"},{"key":"10302_CR108","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejphar.2017.06.031","volume":"812","author":"H Liang","year":"2017","unstructured":"Liang H, Xu F, Wen XJ, Liu HZ, Wang HB, Zhong JY, Yang CX, Zhang B (2017) Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion. Eur J Pharmacol 812:18\u201327","journal-title":"Eur J Pharmacol"},{"key":"10302_CR109","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR (2016) Interleukin-33 in health and disease. Nat Rev Immunol 16:676\u2013689","journal-title":"Nat Rev Immunol"},{"key":"10302_CR110","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/STROKEAHA.119.028515","volume":"51","author":"IA Lissak","year":"2020","unstructured":"Lissak IA, Zafar SF, Westover MB, Schleicher RL, Kim JA, Leslie-Mazwi T, Stapleton CJ, Patel AB, Kimberly WT, Rosenthal ES (2020) Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage. Stroke 51:1128\u20131134","journal-title":"Stroke"},{"key":"10302_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113233","volume":"328","author":"X Liu","year":"2020","unstructured":"Liu X, Hu R, Pei L, Si P, Wang C, Tian X, Wang X, Liu H, Wang B, Xia Z, Xu Y, Song B (2020) Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke. Exp Neurol 328:113233","journal-title":"Exp Neurol"},{"key":"10302_CR112","doi-asserted-by":"publisher","first-page":"21527","DOI":"10.1073\/pnas.2006566117","volume":"117","author":"\u00c5 Ljunggren-Rose","year":"2020","unstructured":"Ljunggren-Rose \u00c5, Natarajan C, Matta P, Pandey A, Upender I, Sriram S (2020) Anacardic acid induces IL-33 and promotes remyelination in CNS. Proc Natl Acad Sci U S A 117:21527\u201321535","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10302_CR113","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. Pharmacol Rev 72:606\u2013638","journal-title":"Pharmacol Rev"},{"key":"10302_CR114","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1189\/jlb.3RI1214-595R","volume":"97","author":"JM Lott","year":"2015","unstructured":"Lott JM, Sumpter TL, Turnquist HR (2015) New dog and new tricks: evolving roles for IL-33 in type 2 immunity. J Leukoc Biol 97:1037\u20131048","journal-title":"J Leukoc Biol"},{"key":"10302_CR115","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuroscience.2018.05.047","volume":"385","author":"Q Luo","year":"2018","unstructured":"Luo Q, Fan Y, Lin L, Wei J, Li Z, Li Y, Nakae S, Lin W, Chen Q (2018) Interleukin-33 Protects Ischemic Brain Injury by Regulating Specific Microglial Activities. Neuroscience 385:75\u201389","journal-title":"Neuroscience"},{"key":"10302_CR116","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2014.12.005","volume":"1597","author":"Y Luo","year":"2015","unstructured":"Luo Y, Zhou Y, Xiao W, Liang Z, Dai J, Weng X, Wu X (2015) Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response. Brain Res 1597:86\u201394","journal-title":"Brain Res"},{"key":"10302_CR117","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","volume":"31","author":"AU L\u00fcthi","year":"2009","unstructured":"L\u00fcthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, Lavelle EC, Martin SJ (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84\u201398","journal-title":"Immunity"},{"key":"10302_CR118","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/molecules27041210","volume":"27","author":"C Ma","year":"2022","unstructured":"Ma C, Hong F, Yang S (2022) Amyloidosis in Alzheimer\u2019s Disease: Pathogeny, Etiology, and Related Therapeutic Directions. Molecules 27:1210","journal-title":"Molecules"},{"key":"10302_CR119","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/brainsci10110802","volume":"10","author":"S Maier","year":"2020","unstructured":"Maier S, Simu M, Hutanu A, Barcutean L, Voidazan S, Bajko Z, Motataianu A, Lata I, Balasa R (2020) Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab. Brain Sci 10:802","journal-title":"Brain Sci"},{"key":"10302_CR120","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-023-01043-8","volume":"20","author":"T Mamuladze","year":"2023","unstructured":"Mamuladze T, Kipnis J (2023) Type 2 immunity in the brain and brain borders. Cell Mol Immunol 20:1290\u20131299","journal-title":"Cell Mol Immunol"},{"key":"10302_CR121","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/jid.2012.185","volume":"132","author":"J Meephansan","year":"2012","unstructured":"Meephansan J, Tsuda H, Komine M, Tominaga S, Ohtsuki M (2012) Regulation of IL-33 expression by IFN-\u03b3 and tumor necrosis factor-\u03b1 in normal human epidermal keratinocytes. J Invest Dermatol 132:2593\u20132600","journal-title":"J Invest Dermatol"},{"key":"10302_CR122","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2020.10.008","volume":"91","author":"B Mei","year":"2021","unstructured":"Mei B, Li J, Zuo Z (2021) Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central \u03b12A adrenoceptor. Brain Behav Immun 91:296\u2013314","journal-title":"Brain Behav Immun"},{"key":"10302_CR123","doi-asserted-by":"publisher","first-page":"1019877","DOI":"10.3389\/fnmol.2022.1019877","volume":"15","author":"E Melamed","year":"2022","unstructured":"Melamed E, Palmer JL, Fonken C (2022) Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis. Front Mol Neurosci 15:1019877","journal-title":"Front Mol Neurosci"},{"key":"10302_CR124","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","volume":"52","author":"M Milovanovic","year":"2012","unstructured":"Milovanovic M, Volarevic V, Radosavljevic G, Jovanovic I, Pejnovic N, Arsenijevic N, Lukic ML (2012) IL-33\/ST2 axis in inflammation and immunopathology. Immunol Res 52:89\u201399","journal-title":"Immunol Res"},{"key":"10302_CR125","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","volume":"42","author":"AB Molofsky","year":"2015","unstructured":"Molofsky AB, Savage AK, Locksley RM (2015) Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity 42:1005\u20131019","journal-title":"Immunity"},{"key":"10302_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13100877","volume":"13","author":"S Mukherjee","year":"2024","unstructured":"Mukherjee S, Ghosh P, Ghosh S, Sengupta A, Sarkar S, Chatterjee R, Saha A, Bawali S, Choudhury A, Daptary AH, Gangopadhyay A, Keswani T, Bhattacharyya A (2024) Administration of rIL-33 restores altered mDC\/pDC ratio, MDSC frequency, and Th-17\/Treg ratio during experimental cerebral malaria. Pathogens 13:877","journal-title":"Pathogens"},{"key":"10302_CR127","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-005-1032-6","volume":"110","author":"M Nakada","year":"2005","unstructured":"Nakada M, Miyamori H, Kita D, Takahashi T, Yamashita J, Sato H, Miura R, Yamaguchi Y, Okada Y (2005) Human glioblastomas overexpress ADAMTS-5 that degrades brevican. Acta Neuropathol 110:239\u2013246","journal-title":"Acta Neuropathol"},{"key":"10302_CR128","doi-asserted-by":"publisher","first-page":"e009236","DOI":"10.1136\/jitc-2024-009236","volume":"12","author":"Y Nan","year":"2024","unstructured":"Nan Y, Bai Y, Hu X, Zhou K, Wu T, Zhu A, Li M, Dou Z, Cao Z, Zhang X, Xu S, Zhang Y, Lin J, Zeng X, Fan J, Zhang X, Wang X, Ju D (2024) Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy. J Immunother Cancer 12:e009236","journal-title":"J Immunother Cancer"},{"key":"10302_CR129","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1053\/j.sult.2019.09.003","volume":"41","author":"I Nguyen","year":"2020","unstructured":"Nguyen I, Urbanczyk K, Mtui E, Li S (2020) Intracranial CNS Infections: A Literature Review and Radiology Case Studies. Semin Ultrasound CT MR 41:106\u2013120","journal-title":"Semin Ultrasound CT MR"},{"key":"10302_CR130","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR (2015) The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol 10:173\u2013194","journal-title":"Annu Rev Pathol"},{"key":"10302_CR131","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.4049\/jimmunol.0802449","volume":"183","author":"T Ohno","year":"2009","unstructured":"Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell RA, Okumura K, Saito H, Nakae S (2009) Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 183:7890\u20137897","journal-title":"J Immunol"},{"key":"10302_CR132","doi-asserted-by":"publisher","first-page":"787713","DOI":"10.3389\/fimmu.2022.787713","volume":"13","author":"E Olgu\u00edn-Mart\u00ednez","year":"2022","unstructured":"Olgu\u00edn-Mart\u00ednez E, Mu\u00f1oz-Paleta O, Ruiz-Medina BE, Ramos-Balderas JL, Licona-Lim\u00f3n I, Licona-Lim\u00f3n P (2022) IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2. Front Immunol 13:787713","journal-title":"Front Immunol"},{"key":"10302_CR133","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ (2016) Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol 173:649\u2013665","journal-title":"Br J Pharmacol"},{"key":"10302_CR134","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1046\/j.1365-2745.2002.01494.x","volume":"32","author":"K Oshikawa","year":"2002","unstructured":"Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y (2002) Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 32:1520\u20131526","journal-title":"Clin Exp Allergy"},{"key":"10302_CR135","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/eji.201545805","volume":"46","author":"F Ottenlinger","year":"2016","unstructured":"Ottenlinger F, Schwiebs A, Pfarr K, Wagner A, Gr\u00fcner S, Mayer CA, Pfeilschifter JM, Radeke HH (2016) Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-\u03b3 production in CD8 (+) lymphocytes. Eur J Immunol 46:941\u2013951","journal-title":"Eur J Immunol"},{"key":"10302_CR136","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/glia.22556","volume":"61","author":"YB Ouyang","year":"2013","unstructured":"Ouyang YB, Xu L, Lu Y, Sun X, Yue S, Xiong XX, Giffard RG (2013) Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia. Glia 61:1784\u20131794","journal-title":"Glia"},{"key":"10302_CR137","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.npep.2016.08.002","volume":"61","author":"B Oztas","year":"2017","unstructured":"Oztas B, Sahin D, Kir H, Eraldemir FC, Musul M, Kuskay S, Ates N (2017) The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-\u0391, Il-1\u03b2, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model. Neuropeptides 61:31\u201337","journal-title":"Neuropeptides"},{"key":"10302_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112365","volume":"18","author":"JN Pearson-Smith","year":"2017","unstructured":"Pearson-Smith JN, Patel M (2017) Metabolic dysfunction and oxidative stress in epilepsy. Int J Mol Sci 18:2365","journal-title":"Int J Mol Sci"},{"key":"10302_CR139","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.it.2016.03.007","volume":"37","author":"M Peine","year":"2016","unstructured":"Peine M, Marek RM, L\u00f6hning M (2016) IL-33 in T Cell Differentiation, Function, and Immune Homeostasis. Trends Immunol 37:321\u2013333","journal-title":"Trends Immunol"},{"key":"10302_CR140","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbi.2014.08.002","volume":"44","author":"Y Pomeshchik","year":"2015","unstructured":"Pomeshchik Y, Kidin I, Korhonen P, Savchenko E, Jaronen M, Lehtonen S, Wojciechowski S, Kanninen K, Koistinaho J, Malm T (2015) Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury. Brain Behav Immun 44:68\u201381","journal-title":"Brain Behav Immun"},{"key":"10302_CR141","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-981-15-0602-4_8","volume":"1206","author":"Z Qi","year":"2019","unstructured":"Qi Z, Chen L (2019) Endoplasmic Reticulum Stress and Autophagy. Adv Exp Med Biol 1206:167\u2013177","journal-title":"Adv Exp Med Biol"},{"key":"10302_CR142","doi-asserted-by":"publisher","first-page":"614","DOI":"10.14336\/AD.2016.0207","volume":"7","author":"L Qian","year":"2016","unstructured":"Qian L, Yuanshao L, Wensi H, Yulei Z, Xiaoli C, Brian W, Wanli Z, Zhengyi C, Jie X, Wenhui Z, Tieer Y, Hong W, Jincai H, Kunlin J, Bei S (2016) Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke. Aging Dis 7:614\u2013622","journal-title":"Aging Dis"},{"key":"10302_CR143","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12967-022-03570-w","volume":"20","author":"X Rao","year":"2022","unstructured":"Rao X, Hua F, Zhang L, Lin Y, Fang P, Chen S, Ying J, Wang X (2022) Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation. J Transl Med 20:369","journal-title":"J Transl Med"},{"key":"10302_CR144","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","volume":"34","author":"GE Raskob","year":"2014","unstructured":"Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI (2014) Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34:2363\u20132371","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10302_CR145","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/cpt.3147","volume":"115","author":"F Reid","year":"2024","unstructured":"Reid F et al (2024) A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease. Clin Pharmacol Ther 115:565\u2013575","journal-title":"Clin Pharmacol Ther"},{"key":"10302_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006322","volume":"13","author":"F Reverchon","year":"2017","unstructured":"Reverchon F, Mortaud S, Sivoyon M, Maillet I, Laugeray A, Palomo J, Mont\u00e9cot C, Herzine A, Meme S, Meme W, Erard F, Ryffel B, Menuet A, Quesniaux VFJ (2017) IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria. PLoS Pathog 13:e1006322","journal-title":"PLoS Pathog"},{"key":"10302_CR147","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, Gendelman HE (2010) Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J Immunol 184:2261\u20132271","journal-title":"J Immunol"},{"key":"10302_CR148","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00011-020-01394-2","volume":"69","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T (2020) Mast cells and angiogenesis in multiple sclerosis. Inflamm Res 69:1103\u20131110","journal-title":"Inflamm Res"},{"key":"10302_CR149","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, Aktas B, Pita C, Ciglar L, Garraux G, Williams-Gray C, Pacheco R, Romero-Ramos M (2024) The immune system in Parkinson\u2019s disease: what we know so far. Brain 147:3306\u20133324","journal-title":"Brain"},{"key":"10302_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010107","author":"AA Rostagno","year":"2022","unstructured":"Rostagno AA (2022) Pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010107","journal-title":"Int J Mol Sci"},{"key":"10302_CR151","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/embor.2008.145","volume":"9","author":"L Roussel","year":"2008","unstructured":"Roussel L, Erard M, Cayrol C, Girard JP (2008) Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 9:1006\u20131012","journal-title":"EMBO Rep"},{"key":"10302_CR152","doi-asserted-by":"publisher","first-page":"e1520","DOI":"10.1073\/pnas.1710401115","volume":"115","author":"AE Russi","year":"2018","unstructured":"Russi AE, Ebel ME, Yang Y, Brown MA (2018) Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proc Natl Acad Sci U S A 115:e1520\u2013e1529","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10302_CR153","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fcimb.2020.00153","volume":"10","author":"N Ryan","year":"2020","unstructured":"Ryan N, Anderson K, Volpedo G, Varikuti S, Satoskar M, Satoskar S, Oghumu S (2020) The IL-33\/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications. Front Cell Infect Microbiol 10:153","journal-title":"Front Cell Infect Microbiol"},{"key":"10302_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107847","volume":"225","author":"AK Saikumar Jayalatha","year":"2021","unstructured":"Saikumar Jayalatha AK, Hesse L, Ketelaar ME, Koppelman GH, Nawijn MC (2021) The central role of IL-33\/IL-1RL1 pathway in asthma: from pathogenesis to intervention. Pharmacol Ther 225:107847","journal-title":"Pharmacol Ther"},{"key":"10302_CR155","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jaci.2012.05.018","volume":"130","author":"RJ Salmond","year":"2012","unstructured":"Salmond RJ, Mirchandani AS, Besnard AG, Bain CC, Thomson NC, Liew FY (2012) IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J Allergy Clin Immunol 130:1159\u20131166e1156","journal-title":"J Allergy Clin Immunol"},{"key":"10302_CR156","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-020-01806-4","volume":"17","author":"M Saresella","year":"2020","unstructured":"Saresella M, Marventano I, Piancone F, La Rosa F, Galimberti D, Fenoglio C, Scarpini E, Clerici M (2020) IL-33 and its decoy sST2 in patients with Alzheimer\u2019s disease and mild cognitive impairment. J Neuroinflammation 17:174","journal-title":"J Neuroinflammation"},{"key":"10302_CR157","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590","journal-title":"Lancet"},{"key":"10302_CR158","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479\u2013490","journal-title":"Immunity"},{"key":"10302_CR159","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ACI.0000000000000981","volume":"24","author":"JP Schuetz","year":"2024","unstructured":"Schuetz JP, Anderson B, Sindher SB (2024) New biologics for food allergy. Curr Opin Allergy Clin Immunol 24:147\u2013152","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10302_CR160","doi-asserted-by":"publisher","first-page":"156015","DOI":"10.1016\/j.cyto.2022.156015","volume":"158","author":"L Shakerian","year":"2022","unstructured":"Shakerian L, Kolahdooz H, Garousi M, Keyvani V, Kamal Kheder R, Abdulsattar Faraj T, Yazdanpanah E, Esmaeili SA (2022) IL-33\/ST2 axis in autoimmune disease. Cytokine 158:156015","journal-title":"Cytokine"},{"key":"10302_CR161","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bbi.2025.07.010","volume":"129","author":"C Shen","year":"2025","unstructured":"Shen C, Liu Z, Chen F, Zhu X, Fan G, Ning P, Li Q, Zhang X, Dong H, Liu Y, Yu M, Fei J, Huang F (2025) Interleukin-33 promotes dopaminergic neuron survival and inhibits glial activation in Parkinson\u2019s disease models. Brain Behav Immun 129:787\u2013800","journal-title":"Brain Behav Immun"},{"key":"10302_CR162","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D (2022) Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation 19:206","journal-title":"J Neuroinflammation"},{"key":"10302_CR163","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12098-017-2487-x","volume":"86","author":"P Singhi","year":"2019","unstructured":"Singhi P, Saini AG (2019) Fungal and Parasitic CNS Infections. Indian J Pediatr 86:83\u201390","journal-title":"Indian J Pediatr"},{"key":"10302_CR164","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1113\/JP279379","volume":"598","author":"Y Srisomboon","year":"2020","unstructured":"Srisomboon Y, Squillace DL, Maniak PJ, Kita H, O\u2019Grady SM (2020) Fungal allergen-induced IL-33 secretion involves cholesterol-dependent, VDAC-1-mediated ATP release from the airway epithelium. J Physiol 598:1829\u20131845","journal-title":"J Physiol"},{"key":"10302_CR165","doi-asserted-by":"publisher","first-page":"7404","DOI":"10.1073\/pnas.1801737115","volume":"115","author":"P Strangward","year":"2018","unstructured":"Strangward P, Haley MJ, Albornoz MG, Barrington J, Shaw T, Dookie R, Zeef L, Baker SM, Winter E, Tzeng TC, Golenbock DT, Cruickshank SM, Allan SM, Craig A, Liew FY, Brough D, Couper KN (2018) Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria. Proc Natl Acad Sci U S A 115:7404\u20137409","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10302_CR166","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5580","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wei K, Liao X, Wang J, Gao L, Pang B (2025) Lipid metabolism in microglia: emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2025.5580","journal-title":"Int J Mol Med"},{"key":"10302_CR167","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/all.15918","volume":"79","author":"A Sverrild","year":"2024","unstructured":"Sverrild A, Cerps S, Nieto-Fontarigo JJ, Ramu S, Hvidtfeldt M, Menzel M, Kearley J, Griffiths JM, Parnes JR, Porsbjerg C, Uller L (2024) Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma. Allergy 79:656\u2013666","journal-title":"Allergy"},{"key":"10302_CR168","doi-asserted-by":"publisher","first-page":"19420","DOI":"10.1074\/jbc.M901744200","volume":"284","author":"D Talabot-Ayer","year":"2009","unstructured":"Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G (2009) Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 284:19420\u201319426","journal-title":"J Biol Chem"},{"key":"10302_CR169","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3233\/JAD-221072","volume":"92","author":"YJ Tan","year":"2023","unstructured":"Tan YJ, Siow I, Saffari SE, Ting SKS, Li Z, Kandiah N, Tan LCS, Tan EK, Ng ASL (2023) Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition. J Alzheimers Dis 92:573\u2013580","journal-title":"J Alzheimers Dis"},{"key":"10302_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH (2023) Neuroinflammation in Alzheimer\u2019s Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation 46:1\u201317","journal-title":"Inflammation"},{"key":"10302_CR171","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393:689\u2013701","journal-title":"Lancet"},{"key":"10302_CR172","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0014-5793(89)81679-5","volume":"258","author":"S Tominaga","year":"1989","unstructured":"Tominaga S (1989) A putative protein of a growth specific cDNA from BALB\/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 258:301\u2013304","journal-title":"FEBS Lett"},{"key":"10302_CR173","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1006\/bbrc.1999.1469","volume":"264","author":"S Tominaga","year":"1999","unstructured":"Tominaga S, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Komatsu N (1999) Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7\/GM. Biochem Biophys Res Commun 264:14\u201318","journal-title":"Biochem Biophys Res Commun"},{"key":"10302_CR174","doi-asserted-by":"publisher","first-page":"107351","DOI":"10.1016\/j.yebeh.2020.107351","volume":"112","author":"ECB Toscano","year":"2020","unstructured":"Toscano ECB, Lessa JMK, de Oliveira GN, Gon\u00e7alves AP, Vieira \u00c9LM, Rachid MA, Teixeira AL (2020) Peripheral levels of sST2 are increased in patients with temporal lobe epilepsy: Additional evidence of low-grade inflammation. Epilepsy Behav 112:107351","journal-title":"Epilepsy Behav"},{"key":"10302_CR175","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaci.2014.06.023","volume":"135","author":"RS Traister","year":"2015","unstructured":"Traister RS, Uvalle CE, Hawkins GA, Meyers DA, Bleecker ER, Wenzel SE (2015) Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma. J Allergy Clin Immunol 135:92\u201399","journal-title":"J Allergy Clin Immunol"},{"key":"10302_CR176","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1038\/jid.2012.180","volume":"132","author":"H Tsuda","year":"2012","unstructured":"Tsuda H, Komine M, Karakawa M, Etoh T, Tominaga S, Ohtsuki M (2012) Novel splice variants of IL-33: differential expression in normal and transformed cells. J Invest Dermatol 132:2661\u20132664","journal-title":"J Invest Dermatol"},{"key":"10302_CR177","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/all.13158","volume":"72","author":"M Uchida","year":"2017","unstructured":"Uchida M, Anderson EL, Squillace DL, Patil N, Maniak PJ, Iijima K, Kita H, O\u2019Grady SM (2017) Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium. Allergy 72:1521\u20131531","journal-title":"Allergy"},{"key":"10302_CR178","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.tips.2019.04.013","volume":"40","author":"LA Valente","year":"2019","unstructured":"Valente LA, Begg LR, Filiano AJ (2019) Updating Neuroimmune Targets in Central Nervous System Dysfunction. Trends Pharmacol Sci 40:482\u2013494","journal-title":"Trends Pharmacol Sci"},{"key":"10302_CR179","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/bmm-2022-0294","volume":"16","author":"N Vlachos","year":"2022","unstructured":"Vlachos N, Lampros MG, Lianos GD, Voulgaris S, Alexiou GA (2022) Blood biomarkers for predicting coagulopathy occurrence in patients with traumatic brain injury: a systematic review. Biomark Med 16:935\u2013945","journal-title":"Biomark Med"},{"key":"10302_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152788","volume":"456","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wu L, Pan B, Chen Y, Zhang T, Tang N (2021) Interleukin 33 mediates hepatocyte autophagy and innate immune response in the early phase of acetaminophen-induced acute liver injury. Toxicology 456:152788","journal-title":"Toxicology"},{"key":"10302_CR181","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nlm.2019.03.002","volume":"161","author":"ZF Wang","year":"2019","unstructured":"Wang ZF, Gao C, Chen W, Gao Y, Wang HC, Meng Y, Luo CL, Zhang MY, Chen G, Chen XP, Wang T, Tao LY (2019) Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model. Neurobiol Learn Mem 161:12\u201325","journal-title":"Neurobiol Learn Mem"},{"key":"10302_CR182","first-page":"vdaf010","volume":"7","author":"G Wicher","year":"2025","unstructured":"Wicher G, Roy A, Vaccaro A, Vemuri K, Ramachandran M, Olofsson T, Imbria RN, Belting M, Nilsson G, Dimberg A, Forsberg-Nilsson K (2025) Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression. Neurooncol Adv 7:vdaf010","journal-title":"Neurooncol Adv"},{"key":"10302_CR183","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1089\/neu.2016.4900","volume":"34","author":"G Wicher","year":"2017","unstructured":"Wicher G, Wallenquist U, Lei Y, Enoksson M, Li X, Fuchs B, Abu Hamdeh S, Marklund N, Hillered L, Nilsson G, Forsberg-Nilsson K (2017) Interleukin-33 Promotes Recruitment of Microglia\/Macrophages in Response to Traumatic Brain Injury. J Neurotrauma 34:3173\u20133182","journal-title":"J Neurotrauma"},{"key":"10302_CR184","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/acn3.435","volume":"4","author":"Z Wolcott","year":"2017","unstructured":"Wolcott Z, Batra A, Bevers MB, Sastre C, Khoury J, Sperling M, Meyer BC, Walsh KB, Adeoye O, Broderick JP, Kimberly WT (2017) Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke. Ann Clin Transl Neurol 4:553\u2013563","journal-title":"Ann Clin Transl Neurol"},{"key":"10302_CR185","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1474-4422(05)70283-0","volume":"5","author":"G Xi","year":"2006","unstructured":"Xi G, Keep RF, Hoff JT (2006) Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 5:53\u201363","journal-title":"Lancet Neurol"},{"key":"10302_CR186","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.molimm.2018.08.026","volume":"101","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Lai L, Chen H, Shi J, Zeng F, Li J, Feng H, Mao J, Zhang F, Wu N, Xu Y, Tan Z, Gong F, Zheng F (2018) Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells. Mol Immunol 101:550\u2013563","journal-title":"Mol Immunol"},{"key":"10302_CR187","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1161\/STROKEAHA.120.032444","volume":"52","author":"D Xie","year":"2021","unstructured":"Xie D, Liu H, Xu F, Su W, Ye Q, Yu F, Austin TJ, Chen J, Hu X (2021) IL33 (Interleukin 33)\/ST2 (Interleukin 1 Receptor-Like 1) Axis Drives Protective Microglial Responses and Promotes White Matter Integrity After Stroke. Stroke 52:2150\u20132161","journal-title":"Stroke"},{"key":"10302_CR188","doi-asserted-by":"publisher","first-page":"860772","DOI":"10.3389\/fimmu.2022.860772","volume":"13","author":"D Xie","year":"2022","unstructured":"Xie D, Miao W, Xu F, Yuan C, Li S, Wang C, Junagade A, Hu X (2022) IL-33\/ST2 Axis Protects Against Traumatic Brain Injury Through Enhancing the Function of Regulatory T Cells. Front Immunol 13:860772","journal-title":"Front Immunol"},{"key":"10302_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.1012968","volume":"16","author":"T Xiong","year":"2022","unstructured":"Xiong T, Wang X, Zha Y, Wang Y (2022) Interleukin-33 regulates the functional state of microglia. Front Cell Neurosci 16:1012968","journal-title":"Front Cell Neurosci"},{"key":"10302_CR190","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-132081","volume":"40","author":"Z Xiong","year":"2014","unstructured":"Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A (2014) Alzheimer\u2019s disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers Dis 40:297\u2013308","journal-title":"J Alzheimers Dis"},{"key":"10302_CR191","doi-asserted-by":"publisher","first-page":"960036","DOI":"10.3389\/fimmu.2022.960036","volume":"13","author":"S Yamamoto","year":"2022","unstructured":"Yamamoto S, Matsui A, Ohyagi M, Kikutake C, Harada Y, Iizuka-Koga M, Suyama M, Yoshimura A, Ito M (2022) In Vitro Generation of Brain Regulatory T Cells by Co-culturing With Astrocytes. Front Immunol 13:960036","journal-title":"Front Immunol"},{"key":"10302_CR192","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/glia.23571","volume":"67","author":"QQ Yang","year":"2019","unstructured":"Yang QQ, Zhou JW (2019) Neuroinflammation in the central nervous system: Symphony of glial cells. Glia 67:1017\u20131035","journal-title":"Glia"},{"key":"10302_CR193","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1523\/JNEUROSCI.3233-16.2017","volume":"37","author":"Y Yang","year":"2017","unstructured":"Yang Y, Liu H, Zhang H, Ye Q, Wang J, Yang B, Mao L, Zhu W, Leak RK, Xiao B, Lu B, Chen J, Hu X (2017) ST2\/IL-33-Dependent Microglial Response Limits Acute Ischemic Brain Injury. J Neurosci 37:4692\u20134704","journal-title":"J Neurosci"},{"key":"10302_CR194","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2011.02.045","volume":"1385","author":"S Yasuoka","year":"2011","unstructured":"Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M, Sonobe Y, Takeuchi H, Mizuno T, Suzumura A (2011) Production and functions of IL-33 in the central nervous system. Brain Res 1385:8\u201317","journal-title":"Brain Res"},{"key":"10302_CR195","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s12276-021-00660-5","volume":"53","author":"SS Yeung","year":"2021","unstructured":"Yeung SS, Ho YS, Chang RC (2021) The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases. Exp Mol Med 53:1251\u20131267","journal-title":"Exp Mol Med"},{"key":"10302_CR196","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1096\/fj.14-267146","volume":"30","author":"AC Zarpelon","year":"2016","unstructured":"Zarpelon AC, Rodrigues FC, Lopes AH, Souza GR, Carvalho TT, Pinto LG, Xu D, Ferreira SH, Alves-Filho JC, McInnes IB, Ryffel B, Quesniaux VF, Reverchon F, Mortaud S, Menuet A, Liew FY, Cunha FQ, Cunha TM, Verri WA Jr (2016) Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. Faseb j 30:54\u201365","journal-title":"Faseb j"},{"key":"10302_CR197","doi-asserted-by":"publisher","first-page":"106461","DOI":"10.1016\/j.nbd.2024.106461","volume":"193","author":"J Zeng","year":"2024","unstructured":"Zeng J, Liao Z, Yang H, Wang Q, Wu Z, Hua F, Zhou Z (2024) T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer\u2019s disease. Neurobiol Dis 193:106461","journal-title":"Neurobiol Dis"},{"key":"10302_CR198","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/acn3.47","volume":"1","author":"F Zhang","year":"2014","unstructured":"Zhang F, Tossberg JT, Spurlock CF, Yao SY, Aune TM, Sriram S (2014) Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis. Ann Clin Transl Neurol 1:307\u2013318","journal-title":"Ann Clin Transl Neurol"},{"key":"10302_CR199","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/00207454.2016.1175441","volume":"127","author":"J Zhang","year":"2017","unstructured":"Zhang J, Wang P, Ji W, Ding Y, Lu X (2017a) Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma. Int J Neurosci 127:210\u2013217","journal-title":"Int J Neurosci"},{"key":"10302_CR200","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3892\/or.2017.5926","volume":"38","author":"JF Zhang","year":"2017","unstructured":"Zhang JF, Wang P, Yan YJ, Li Y, Guan MW, Yu JJ, Wang XD (2017b) IL\u201333 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-\u03baB pathway. Oncol Rep 38:2033\u20132042","journal-title":"Oncol Rep"},{"key":"10302_CR201","doi-asserted-by":"publisher","first-page":"e121560","DOI":"10.1172\/jci.insight.121560","volume":"3","author":"SR Zhang","year":"2018","unstructured":"Zhang SR, Piepke M, Chu HX, Broughton BR, Shim R, Wong CH, Lee S, Evans MA, Vinh A, Sakkal S, Arumugam TV, Magnus T, Huber S, Gelderblom M, Drummond GR, Sobey CG, Kim HA (2018) IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke. JCI Insight 3:e121560","journal-title":"JCI Insight"},{"key":"10302_CR202","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2019.07.008","volume":"497","author":"ZY Zhang","year":"2019","unstructured":"Zhang ZY, Li J, Ye Q, Dong Y, Bao GM, Shen YK, Weng JF, Luo LF, Cen M (2019) Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury. Clin Chim Acta 497:6\u201312","journal-title":"Clin Chim Acta"},{"key":"10302_CR203","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/ni.2341","volume":"13","author":"J Zhao","year":"2012","unstructured":"Zhao J, Wei J, Mialki RK, Mallampalli DF, Chen BB, Coon T, Zou C, Mallampalli RK, Zhao Y (2012) F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat Immunol 13:651\u2013658","journal-title":"Nat Immunol"},{"key":"10302_CR204","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/08977151251401226","volume":"43","author":"R Zhao","year":"2025","unstructured":"Zhao R, Gao SQ, Wang X, Li T, Gao CC, Han YL, Qiu JY, Miao SH, Sun Y, Zheng XB, Jin WX, Zhou ML (2025) YAP Regulates Microglial Anti-Inflammatory Responses and Alleviates Cognitive Impairment Through the IL-33\/ST2 Pathway after Traumatic Brain Injury. J Neurotrauma 43:641\u2013659","journal-title":"J Neurotrauma"},{"key":"10302_CR205","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/cmi.2010.3","volume":"7","author":"W Zhao","year":"2010","unstructured":"Zhao W, Hu Z (2010) The enigmatic processing and secretion of interleukin-33. Cell Mol Immunol 7:260\u2013262","journal-title":"Cell Mol Immunol"},{"key":"10302_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107541","volume":"95","author":"C Zheng","year":"2021","unstructured":"Zheng C, Lu Z, Wu H, Cui L, Bi J, Wan X (2021) Exogenous oxidative stress suppresses IL-33 -driven proliferation programming in group 2 innate lymphoid cells. Int Immunopharmacol 95:107541","journal-title":"Int Immunopharmacol"},{"key":"10302_CR207","doi-asserted-by":"publisher","first-page":"3","DOI":"10.31083\/j.fbs1401003","volume":"14","author":"SG Zubova","year":"2022","unstructured":"Zubova SG, Suvorova II, Karpenko MN (2022) Macrophage and microglia polarization: focus on autophagy-dependent reprogramming. Front Biosci (Schol Ed) 14:3","journal-title":"Front Biosci (Schol Ed)"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-026-10302-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:02:23Z","timestamp":1783699343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-026-10302-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10302"],"URL":"https:\/\/doi.org\/10.1007\/s11481-026-10302-0","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}